Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Attorney Spotlight: Kinika Young

December 10, 2014
Kinika Young Tell us about your practice.

I primarily represent healthcare providers in manage care disputes, risk management, and professional liability matters. I advise my clients during the pre-litigation phase in attempts to negotiate favorable results without taking legal action. I also handle arbitration and litigation matters on behalf of providers against third party payers, requiring in-depth research, briefing, and analysis of complex legal issues, such as ERISA preemption, the Affordable Care Act implementation, and various state laws concerning "any willing provider" provisions. 

What are some trends you are seeing related to the legal industry or in the industry in which you practice?

The passage of the Affordable Care Act has affected all stakeholders in the healthcare industry – patients, providers, and payers. Given the finite resources and infinite demands on the healthcare system, payers have become more aggressive by creating narrow networks, taking hard positions in contract negotiations, adopting restrictive claims handling policies and procedures, and raising premiums, all while lowering payments to providers. Healthcare providers should be aware of the common payment challenges that third party payers are lodging. Providers need to understand their rights and avoid costly mistakes to obtain proper reimbursement for their services. Providers should develop an offensive strategy to protect their business interests and prepare for the impact that lengthy payment delays may have on their revenue stream. They should also factor in the role that patients can play in resolving these disputes and look to patients as their allies. 

How did your recent trip to Cuba to observe the country's healthcare system affect your practice?

Witnessing firsthand how a healthcare system can operate with very limited resources and still manage to take proactive steps to address common healthcare needs inspired me to think more creatively about the problems that my clients face. Even the most complicated issues can be resolved by identifying common goals and creative solutions.


Related Professionals

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.